Analystreport

Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $535.00 price target on by analysts at UBS Group AG.

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com